Filing Details

Accession Number:
0001214659-24-014768
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-14 18:01:00
Reporting Period:
2024-08-06
Accepted Time:
2024-08-14 18:01:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1677077 Alzamend Neuro Inc. ALZN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212502 Iii C Milton Ault 11411 Southern Highlands Parkway
Suite 240
Las Vegas NV 89141
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-06 75 $2.75 77,268 No 4 P Indirect By Ault Lending, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Ault Lending, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 16,686 Direct
Common Stock 99,619 Indirect By Ault Life Sciences, Inc.
Common Stock 549 Indirect By Ault Life Sciences Fund, LLC
Footnotes
  1. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
  2. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
  3. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.